首页> 外文期刊>Medicine. >Intraoperative portal vein insulin assay combined with occlusion of the pancreas for complex pancreatogenous hypoglycemia: Two cases report
【24h】

Intraoperative portal vein insulin assay combined with occlusion of the pancreas for complex pancreatogenous hypoglycemia: Two cases report

机译:术中门静脉胰岛素测定结合复合胰腺源性低血糖的胰腺闭塞:两种情况报告

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Intraoperative localization and confirmation of complete resection of the hypersecreting tissue are the 2 main challenges in the management of pancreatogenous hypoglycemia. Here, we report our experience with intraoperative portal vein insulin assay combined with occlusion of the pancreas in the management of pancreatogenous hypoglycemia. Clinical courses of 2 patients with biochemical evidence of a pancreatogenous hypoglycemia were studied. The preoperative diagnosis was multiple endocrine neoplasia 1 (MEN-1) and nesidioblastosis, respectively. Rapid intraoperative portal vein insulin assay combined with occlusion of the pancreas was used to localize and confirm complete excision of the hypersecreting tissue. Hypoglycemia was successfully treated in both the patients. In the MEN-1 patient, 2 small tumors in the head of pancreas were not resected, as they were deemed noninsulin secreting by intraoperative portal vein insulin assay, thus avoiding a total pancreatectomy. In the patient with nesidioblastosis, using intraoperative portal vein insulin assay combined with occlusion of the pancreas, an appropriate amount of pancreatic tissue was resected thereby avoiding recurrence and diabetes. This technique may be of particular value in patients with complex conditions such as MEN-1 and nesidioblastosis, to localize and achieve complete resection of hypersecreting pancreatic tissue.
机译:完全切除的术中定位和确认过度分泌组织是胰腺源性低血糖管理中的2个主要挑战。在这里,我们报告了我们对术中门静脉胰岛素测定的经验,这些胰岛素测定结合胰腺的闭塞在胰腺源性低血糖管理中。研究了2例生化证据的临床疗程,研究了胰腺源性低血糖的生化证据。术前诊断分别是多个内分泌瘤形成1(男性1)和Nesidioblastosissis。快速术中门静脉胰岛素测定与胰腺的闭塞结合定位并确认完全切除过度的组织。低血糖在患者中成功治疗。在MEN-1患者中,胰腺头部的2个小肿瘤未被切除,因为它们被术中门静脉胰岛素测定被视为非胰岛素分泌,因此避免了总胰腺切除术。在患有Nesidioblastosis的患者中,使用术中门静脉胰岛素测定与胰腺的闭塞结合,切除了适量的胰腺组织,从而避免了复发和糖尿病。该技术可能对诸如Men-1和Nesidioblastosis的复杂条件的患者具有特殊价值,以定位和实现完全切除过度的胰腺组织。

著录项

  • 来源
    《Medicine.》 |2016年第26期|共5页
  • 作者单位

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

    China Japan Friendship Hosp Dept Hepatobiliary Surg 2 East Yinghuayuan St Beijing 100029;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 医药、卫生;
  • 关键词

    intraoperative portal vein insulin assay; multiple endocrine neoplasia; nesidioblastosis; pancreatogenous hypoglycemia; surgical strategy;

    机译:术中门静脉胰岛素测定;多个内分泌瘤形成;Nesidioblastosis;胰腺炎低血糖;手术策略;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号